Evidence indicates that IL-17A may also have a role in promoting metastasis by eliciting expansion and polarization of neutrophils that suppress cytotoxic CD8 T lymphocytes in mouse mammary tumors, thereby promoting metastasis, which may be abrogated by neutralization of IL-17A16. The gene discussed is IL17A; the disease is breast cancer.